New article published Jul 2023
Our article about possible improvements in urinary catheterization published. The role of nurses and the innovation in medical devices are key to improve work efficiency. Non aseptic insertion is one of the most important route causes of CAUTI.
Read our article here
Read our article here
Rethink Medical obtains significant funding through CDTI, as one of the best valued projects at the European level
Jun 2023
Rethink Medical has been awarded a 1.5 million euro grant from the Center for Industrial Technological Development (CDTI), ranking sixth with the highest score at the national level.
The medical innovation startup received this prestigious grant thanks to the Seal of Excellence achieved in the EIC Accelerator Program (Horizon Europe).
The duration will be two years and the funds will be used mainly for an international clinical trial and the certification of the company's first device, the T-Control® urinary catheter.
With this important achievement, Rethink Medical is in a privileged position to continue innovating in the field of health and medical technology, focused mainly on nursing, in which Manuel Luque, nurse and co-founder of the startup, has international experience.
#CDTI #Innovation #Health
The medical innovation startup received this prestigious grant thanks to the Seal of Excellence achieved in the EIC Accelerator Program (Horizon Europe).
The duration will be two years and the funds will be used mainly for an international clinical trial and the certification of the company's first device, the T-Control® urinary catheter.
With this important achievement, Rethink Medical is in a privileged position to continue innovating in the field of health and medical technology, focused mainly on nursing, in which Manuel Luque, nurse and co-founder of the startup, has international experience.
#CDTI #Innovation #Health
New collaborations to shed more light on nursing May 2023
We started a new study in Belgium. We will soon see how our T-Control® probe can facilitate the work of midwives. In collaboration with Artevelde Academy we evaluate the usability of T-Control® in a different environment, but equally relevant.
The first midwives who have had the opportunity to participate in the study have shown very good acceptance, both of the probe itself, and of its accessory that facilitates the mobilization of patients and offers a more comfortable alternative.
#NextGenerationEU #CanariasavanzaconEuropa #SODECAN #FondoCanariasfinancia #UnionEuropea #GobiernodeCanarias
The first midwives who have had the opportunity to participate in the study have shown very good acceptance, both of the probe itself, and of its accessory that facilitates the mobilization of patients and offers a more comfortable alternative.
#NextGenerationEU #CanariasavanzaconEuropa #SODECAN #FondoCanariasfinancia #UnionEuropea #GobiernodeCanarias
Lets get ready to start our clinical essays May 2023
In May we visited the Hospital Madrileño 12 de Octubre, where we will soon begin one of our studies with our T-Control urinary catheter. After all these years of development, the time has finally come for it to start being used in humans.
No doubt moments of great excitement are coming!
#innovation #nursing #vesical probe #clinical study
No doubt moments of great excitement are coming!
#innovation #nursing #vesical probe #clinical study
Presentation at the European Congress of Urology March 2023
Once again we have been present both in the general nursing congress and in the specific nursing one. On this occasion we were able to present an abstract at the UAE and a poster at the EAUN. In both congresses T-Control® and the novelty it brings generated great expectations and curiosity on the part of the participants. More info
ISO 13485 May 2023
Undoubtedly, one of the most important events of this beginning of the year has been the achievement of the ISO 13485 quality certificate. It is a great step that not only shows that we are doing things well but also brings us closer to Obtaining the CE marking certificate to enter the European market.
Members at a discussion panel at the Patent Week Sep 2022
The ULPGC and its Patent Week initiative had us for a round table where some of the most representative companies of innovation on the islands met. It was undoubtedly great news to be able to see university students, start-ups, politicians and directors of the University gathered in the same room. Without a doubt, it was a great pride and pleasure that they had us to share our know-how acquired in the last decade in IP.
New incorporation Aug 2022
Our company has been one of the only three companies in the Canary Islands to get a Research grant through the INVESTIGO program. This has allowed us have in our team a Subsidized Junior Researcher. Clara Armas, graduated in Biomedicine from the University of Seville and studies graduate degree at the University of Murcia.
Clara will help us in planning and carrying out studies of validation and will also participate in the exploration of possible new markets, such as the vet.
This action is part of the "Recovery, transformation and resilience plan financed by the European Union through the Next Generation EU funds.
Clara will help us in planning and carrying out studies of validation and will also participate in the exploration of possible new markets, such as the vet.
This action is part of the "Recovery, transformation and resilience plan financed by the European Union through the Next Generation EU funds.
Rethink Medical obtain funding from SODECAN Jul 2022
Last Wednesday, July 27, the signing of the funding granted by SODECAN took place, for the amount of EIGHT HUNDRED AND FORTY-NINE THOUSAND FOUR HUNDRED AND FORTY-THREE EUROS (€849,443.00), to finance the project called “T- CONTROL®. INNOVATIVE URINARY CATHETER DESTINED TO REDUCE INFECTIONS, INCREASE THE QUALITY OF LIFE OF PATIENTS AND IMPROVE THE EFFICIENCY OF WORK IN THE HOSPITAL”.
The funding was granted within the framework of the Ordinary Loan Line for SME Business Innovation of the Canarias Financia 1 Fund, which aims to grant ordinary loans to help improve the competitiveness of Canarian SMEs by promoting their technological modernization, organization and business management, as well as the development and implementation of new processes and products in the Canary Islands.
The funding was granted within the framework of the Ordinary Loan Line for SME Business Innovation of the Canarias Financia 1 Fund, which aims to grant ordinary loans to help improve the competitiveness of Canarian SMEs by promoting their technological modernization, organization and business management, as well as the development and implementation of new processes and products in the Canary Islands.
Members at a panel discussion about innovation Jun 2022
We were invited to a panel discussion on the occasion of the conference “Emerging technology companies as an engine of innovation: Transforming collaboration between industry and knowledge agents”.
Many thanks to the Canarian Association of Start-up Emerge for having this great initiative. It was undoubtedly a great experience, as well as a great opportunity to exchange the way of seeing innovation from the different actors that intervene in the archipelago, among which were representatives of both universities, the Government of the Canary Islands, the Canary Islands Health Service and of large, medium and small companies.
Many thanks to the Canarian Association of Start-up Emerge for having this great initiative. It was undoubtedly a great experience, as well as a great opportunity to exchange the way of seeing innovation from the different actors that intervene in the archipelago, among which were representatives of both universities, the Government of the Canary Islands, the Canary Islands Health Service and of large, medium and small companies.
European Urology Congress Jun 2022
Our CIO had the honor of being able to exhibit our Living Lab with T-Control® at the European Congress of Urology and the European Urology Congress of Nursing. A great opportunity to show our device and the great benefits it brings, which were well received by the attending public.
#UAE #Urology
#UAE #Urology
EMPRENDEDORES Magazine Jun 2022
If you are in the world of entrepreneurship in Spain, you have undoubtedly heard of the Emprendedores magazine. Undoubtedly a national reference that this month has dedicated an article to our CEO Szilvia Endrenyi, where she shares some experiences and reflections on our company and first project, T-Control®.
For more info: Link
For more info: Link
Spanish Urology Congress Jun 2022
Proud to present our project at the AEU Congress hand in hand with Continentia Foundation. Thank you all for your contribution!
EATIC 2022 Feb 2022
An honor to have been one of the beneficiary companies in the #EATIC 2022 call. Thank you for your trust and support. We will continue contributing to the generation of knowledge and its application in real life.@agenciaiisi @Red_CIDE
Presenters at the EAU Jan 2022
Improvements in indwelling bladder catheterization. Honoured to present our study at the “Affordable techniques in urology” session at the #EAU22 Congress. Thanks to the European Association of Urology (EAU), Healthcare Living Lab Catalonia, EIT Health and CIMTI
For more info: Link
For more info: Link

Semifinalist in Innostar awards May 2021
One more recognition for this project that makes us among the semi-finalists of Innostar Awards 2021. Regardless of whether or not we reached the finals, we are very grateful to have received this award from an institution of such reputation as Eit Health.
For more info: Link
For more info: Link
Winner of pitching event February 2021
We are very happy to announce that we have won the pitching event held among the 15 projects that have participated in the Mentorday acceleration program, an accelerator promoted by ENDESA
CSC Forum “Sanitary products and other medical devices in the context of the COVID-19 pandemic" January 2021
Our invitation to this forum organised by the Consortium of Health and Social of Catalonia turned out to be a success. After our pitching, the attendees rated our company very positively. 92% agreed that T-Control® is a very interesting project.
EIT Health support for pre-clinical validation August 2020
Many thanks for the EIT Health grant approved for our Living Lab activities with nurses! Stay tuned for the update!
Superiority vs gold standard demonstrated by in-vitro model July 2020
Biofilm creation - among others - is one of the most important factors linked to infections and almost the only one that can be measured through simulation.
T-Control® demonstrated superiority vs gold standard, i.e. significant differences were observed between the biofilm quantity generated on the product´s surface.
This result reinforces the hypothesis that T-Control®, with it´s multifactorial approach towards infection prevention addressing several route-causes at the same time, has high chances to show significant benefits in clinical settings.
T-Control® demonstrated superiority vs gold standard, i.e. significant differences were observed between the biofilm quantity generated on the product´s surface.
This result reinforces the hypothesis that T-Control®, with it´s multifactorial approach towards infection prevention addressing several route-causes at the same time, has high chances to show significant benefits in clinical settings.
Validation through Patient Journey Mapping March 2020

Wearing a urinary catheter represents a huge challenge for patients, with Quality of Life implications right from the first moment. Catheter-related Quality of Life studies are scarce, so we decided to organize a specific workshop with patients from different clinical backgrounds in order to openly talk about their experience.
We also managed to introduce the T-Control® concept to the participants and analyze the added value of the product in the whole Patient Journey.
Many thanks for our partners, IEXP Patient Experience Institute and Asociación Continentia for the collaboration.
Results to be published soon!
We also managed to introduce the T-Control® concept to the participants and analyze the added value of the product in the whole Patient Journey.
Many thanks for our partners, IEXP Patient Experience Institute and Asociación Continentia for the collaboration.
Results to be published soon!
Winner of the Entrepreneur Awards Mapfre Guanarteme and FULP 2019
Once again, we are on the newspaper. We are happy to inform that we have been selected as one of the winners of the Entrepreneur Awards organized by FUNDACION MAPFRE Guanarteme and the University´s Foundation of Las Palmas.
We are very grateful for this recognition of the effort and perseverance. We really appreciate all the trust placed in us. #entrepreneurship #awards
For more info: Link
We are very grateful for this recognition of the effort and perseverance. We really appreciate all the trust placed in us. #entrepreneurship #awards
For more info: Link
Among the best projects WER 2019
Very pleased to be one of the 30 selected #FemaleEntrepreneurs with one of the few medicaldevices and the only tangible product at the WER19 event in Madrid. This event is one of the most important initiatives to support women entrepreneurs and give visibility to the projects that they are leading.
For more info: Link
For more info: Link
Great reception of T-Control® Healthio 2018
T-Control® received an extremely positive feedback at HealthIO Global 2018, one of the most important events in Europe in the medical innovation field. It brings together patients, healthcare professionals and innovators in order to understand each other´s needs and find innovative solutions. T-Control® was specially appreciated by nurses who clearly see the advantages it can offer them and their patients on a day to day basis.
For more information: Link
For more information: Link
SME Instrument granted Horizon2020
2018 June starts with good news! We have been granted an SME Phase I Instrument grant, as part of European initiatives supporting innovation. More and more opportunities are helping us bring our idea to market place!
For more information: Link
For more information: Link
Second round! MassChallenge
We have been selected for the 2nd round of the very demanding selection process of MassChallenge, Boston. Out of 1.700 projects presented, 300 got to this phase. We are very proud of our work!
For more information: Link
For more information: Link
Acceleration! Cimti 2018
The first days of 2018 have brought us very good news! T- Control ®, has been selected to be part of the accelarator program of Cimti (Center for the Integration of Medicine and Innovative Technologies in Catalonia).
For more information: Link
For more information: Link
European Funds Eit Health 2017
It is an honour to be able to announce that Rethink Medical was selected as one of the 5 best projects submitted to the EIT Health Headstart competition in Spain, which is It is a highly prominent organisation. Thank you very much to all those who contributed to make this happen!
For more information: Link
For more information: Link
Investor Forum Forum HealthCare 2017
On 23rd February we had the opportunity to be one of the 10 startups presenting at the 18th Investment Forum Healthcare Barcelona, organised by ESADE Business Angel Network, Barcelona Physicians Association, Barcelona Activa - Barcelona City Council and Biocat.
bit.ly/2lJe5Eu #ForumHealthcare
bit.ly/2lJe5Eu #ForumHealthcare
New partner Continentia Association
In January 2017 we signed a collaboration agreement with Continentia Association. The Association, created by a group of specialists in the field of urology, focused on research of incontinence-related diseases and professional training in this field. Incorporating their experience and extensive knowledge is a great value to us.
Dr. José Emilio Batista, president of the Association, is a well-reputed urologist with international experience. He is a scientific researcher, author of several articles in international and national publications, speaker at professional congresses and training programs and holder of the prize for Professional Excellence of the Medical Society of Barcelona.
Dr. José Emilio Batista, president of the Association, is a well-reputed urologist with international experience. He is a scientific researcher, author of several articles in international and national publications, speaker at professional congresses and training programs and holder of the prize for Professional Excellence of the Medical Society of Barcelona.
Se le informa que esta Web utiliza Cookies propias y de terceros, que permiten ofrecer nuestros servicios y mejora de navegación. Si continúa navegando, entendemos que da su consentimiento y acepta el uso que hacemos de las cookies. Puede obtener más información, o bien conocer cómo cambiar la configuración, en nuestra Política de Cookies.
La sonda urinaria T-Control® está pendiente de certificación reglamentaria - No disponible para la venta comercial.
RETHINK MEDICAL S.L. ha recibido un préstamo ordinario de Línea Financiera para la innovación empresarial para PYMES, del Fondo Canarias Financia 1, para la financiación del proyecto denominado “CATÉTER URINARIO INNOVADOR DESTINADO A REDUCIR LAS INFECCIONES, AUMENTAR LA CALIDAD DE VIDA DE LOS PACIENTES Y MEJORAR LA EFICIENCIA DEL TRABAJO EN EL HOSPITAL”, cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER) en un 85% a través del Programa Operativo FEDER de Canarias 2014-2020, contribuyendo al cumplimiento de los objetivos del eje prioritario 1 "Potenciar la investigación, el desarrollo tecnológico y la innovación", Objetivo Específico 1.2.1 "Impulso y promoción de actividades de I+i lideradas por las empresas, apoyo a la creación y consolidación de empresas innovadoras y apoyo a la compra pública innovadora.”
Para más información hacer click aquí
Para más información hacer click aquí
© COPYRIGHT 2015.
ALL RIGHTS RESERVED.
ALL RIGHTS RESERVED.
Support |
Company |